1.1
Middle meningeal artery embolisation for chronic subdural haematomas should be used only in research. Find out what only in research means on the NICE interventional procedures guidance page.
Middle meningeal artery embolisation for chronic subdural haematomas should be used only in research. Find out what only in research means on the NICE interventional procedures guidance page.
Further research could be analysis of registry data with long-term outcomes, randomised controlled trials or other suitably designed studies. It should report details of patient selection, technique used, rebleeding, functional outcomes, need for reintervention and length of hospital stay.
Why the committee made these recommendations
The evidence was limited in quantity and quality. It included a large number of people with chronic subdural haematomas, but only a small number had this procedure. And the procedure was used at different treatment stages and with different aims, including being used alone or with surgery. So, it is uncertain which people may benefit from the procedure.
There are no safety concerns from the evidence, although the procedure can have complications. Overall, there is uncertainty about the efficacy of the procedure. So, it should be used only in research.